Why are lifestyle changes essential for long-term success in medical weight loss? In HelloNation, Medical Weight Loss Expert Pat ...

A real-world study finds that adults with obesity or overweight and related comorbidities who receive antiobesity medications through a telehealth clinic achieve substantial long-term weight loss.

India's drug regulator has warned pharmaceutical companies against direct or indirect advertising of weight-loss medicines, including obesity awareness campaigns that could act as surrogate ...

Fintel reports that on February 13, 2026, Wolfe Research downgraded their outlook for Inspire Medical Systems (NYSE:INSP) from Outperform to Peer Perform. Analyst Price Forecast Suggests 119.36% ...

Evelyn Parr received funding from the Australian government's Medical Research Future Fund and the Diabetes Australia Research Program for work on time-restricted eating. Intermittent fasting has ...

Share on Pinterest People who lose weight with GLP-1 drugs are likely to continue using the medication despite the side effects. Image Credit: geckophotos/Getty Images A recent study found that many ...

Inspire Medical Systems Inc. (NYSE:INSP) is one of the best medical technology stocks to invest in. On February 12, Stifel lowered its price target on Inspire Medical Systems Inc. (NYSE:INSP) to $95 ...

Share on Pinterest A new review of evidence found that intermittent fasting is no better than other dietary patterns for weight loss. yunxi xie/Getty Images Researchers report that intermittent ...

On February 12, 2026, Wells Fargo analyst Larry Biegelsen adjusted his rating for Inspire Medical Systems, Inc. (ticker: INSP) from a more favorable classification to an Equal-Weight. This change ...

Share on Pinterest Weight loss jabs may come with a small risk of acute pancreatitis. But how concerned should people be? Image credit: Varlay/Getty Images GLP-1 receptor agonists, a class of ...

Fourth quarter revenue growth of 12% and full year revenue growth of 14% Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65 Full year net income per ...